Pharmacology of cefazolin in human volunteers.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMID 4199213)

Published in J Clin Pharmacol on October 25, 1973

Authors

P Nicholas, B R Meyers, S Z Hirschman

Articles by these authors

Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med (1981) 5.44

A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet (1999) 4.96

Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med (1982) 3.58

A neighbor-interaction analysis of the hypochromism and spectra of DNA. J Mol Biol (1965) 3.24

Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis (1993) 3.16

Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41

Quantitative microassay in cell culture for enterotoxin of Shigella dysenteriae. J Infect Dis (1972) 2.40

Cefamandole: antimicrobial activity in vitro of a new cephalosporin. Antimicrob Agents Chemother (1975) 2.38

Determination of DNA composition and concentration by spectral analysis. J Mol Biol (1966) 2.12

Treatment of bacterial endocarditis with cephalothin. N Engl J Med (1968) 2.12

Expression of cloned hepatitis B virus DNA in human cell cultures. Proc Natl Acad Sci U S A (1980) 2.08

Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med (1981) 1.96

Bloodstream infections in the elderly. Am J Med (1989) 1.80

Cryptococcal skeletal infections: case report and review. Rev Infect Dis (1990) 1.80

Pharmacological studies with cefamandole in human volunteers. Antimicrob Agents Chemother (1976) 1.68

Patient survival factors in paranasal sinus mucormycosis. Laryngoscope (1980) 1.68

Pharmacologic studies on tobramycin and comparison with gentamicin. J Clin Pharmacol New Drugs (1972) 1.66

Cephanone: in vitro antibacterial activity and pharmacology in normal human volunteers. Antimicrob Agents Chemother (1972) 1.64

Comparison of the antibacterial activities of sisomicin and gentamicin against gram-negative bacteria. Antimicrob Agents Chemother (1975) 1.62

Microbiological and pharmacological behavior of 7-chlorolincomycin. Appl Microbiol (1969) 1.60

Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.58

Renal aspergilloma: an unusual cause of infection in a patient with the acquired immunodeficiency syndrome. Am J Med (1992) 1.56

Tobramycin: in vitro antibacterial spectrum of a new aminoglycoside. J Clin Pharmacol New Drugs (1972) 1.55

Cephapirin: in vitro antibacterial spectrum. Appl Microbiol (1971) 1.50

'Normal' CSF in bacterial meningitis. JAMA (1980) 1.46

Autism and the X chromosome. Multipoint sib-pair analysis. Arch Gen Psychiatry (1996) 1.42

Central nervous system infections in the elderly. Arch Intern Med (1989) 1.40

Cephapirin: pharmacology in normal human volunteers. J Clin Pharmacol New Drugs (1972) 1.36

Genetics of autism: characteristics of affected and unaffected children from 37 multiplex families. Am J Med Genet (1994) 1.35

Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics. Antimicrob Agents Chemother (1980) 1.35

Purification of naked intranuclear particles from human liver infected by hepatitis B virus. Proc Natl Acad Sci U S A (1974) 1.33

Infection due to Actinobacillus actinomycetemcomitans. Am J Clin Pathol (1971) 1.30

Pharmacokinetic study of netilmicin. Antimicrob Agents Chemother (1977) 1.28

D.N.A. polymerase in preparations containing Australia antigen. Lancet (1971) 1.27

Infections caused by microorganisms of the genus Erwinia. Ann Intern Med (1972) 1.27

Cephalexin: microbiological effects and pharmacologic parameters in man. Clin Pharmacol Ther (1969) 1.25

Endocarditis caused by Lactobacillus plantarum. Ann Intern Med (1973) 1.25

Syphilitic osteomyelitis with diffusely abnormal bone scan. Mt Sinai J Med (1979) 1.25

Increased incidence of cholelithiasis in Laënnec's cirrhosis. A postmortem evaluation of pathogenesis. Gastroenterology (1972) 1.22

Pharmacologic studies with cefaclor, a new oral cephalosporin. J Clin Pharmacol (1978) 1.20

Pharmacokinetics of ampicillin-sulbactam in healthy elderly and young volunteers. Antimicrob Agents Chemother (1991) 1.19

Mycobacterial meningitis. Retrospective analysis from 1970 to 1983. Am J Med (1985) 1.19

Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin Infect Dis (1994) 1.18

Clinical study of the use of the new aminoglycoside tobramycin for therapy of infections due to gram-negative bacteria. Antimicrob Agents Chemother (1974) 1.17

Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis (1996) 1.16

Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Intern Med (1992) 1.15

Erythromycin: clinical review I. Clinical pharmacology. N Y State J Med (1977) 1.14

Coxsackie virus myopericarditis. A microbiological and clinical review. Am J Cardiol (1974) 1.13

A continuing outbreak of multidrug-resistant tuberculosis, with transmission in a hospital nursery. Clin Infect Dis (1998) 1.12

Antimicrobial activity of cefamandole against Salmonella typhi. Antimicrob Agents Chemother (1977) 1.09

Current patterns of infection in multiple myeloma. Am J Med (1972) 1.08

Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen. J Immunol (1981) 1.07

Antibacterial activity of cefamandole in vitro. J Infect Dis (1978) 1.06

Absence of linkage and linkage disequilibrium to chromosome 15q11-q13 markers in 139 multiplex families with autism. Am J Med Genet (1999) 1.06

Sensitive indicators of inorganic mercury toxicity. Arch Environ Health (1986) 1.06

Integrator enzyme hypothesis for replication of hepatitis-B virus. Lancet (1975) 1.06

Comparative toxicities of third-generation cephalosporins. Am J Med (1985) 1.06

Bacteriological, pharmacological, and clinical studies of carbenicillin. Arch Intern Med (1970) 1.05

14 C-glucose oxidation in whole blood: a clinical assay for phagocyte dysfunction. Infect Immun (1972) 1.05

Pharmacokinetics of tobramycin in patients with stable renal impairment, patients undergoing peritoneal dialysis, and patients on chronic hemodialysis. Antimicrob Agents Chemother (1974) 1.05

Inhibitors of DNA polymerases of murine leukemia viruses: activity of ethidium bromide. Science (1971) 1.05

Pharmacokinetic parameters of sisomicin. Antimicrob Agents Chemother (1976) 1.03

Susceptibilities of gram-negative bacteria to combinations of antimicrobial agents in vitro. Antimicrob Agents Chemother (1975) 1.03

Fatal infections associated with Mycoplasma pneumoniae: discussion of three cases with necropsy findings. Mt Sinai J Med (1972) 1.00

DNA cloned from the ayw subtype of hepatitis B virus. J Med Virol (1980) 1.00

Concentration of clindamycin in human bone. Antimicrob Agents Chemother (1975) 0.99

Infection of human cells in culture with hepatitis B virus. Trans Assoc Am Physicians (1980) 0.97

Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis. Antimicrob Agents Chemother (1981) 0.97

Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers. Antimicrob Agents Chemother (1983) 0.97

Effect of cytosine arabinoside on the replication of the Moloney sarcoma virus in 3T3 cell cultures. J Natl Cancer Inst (1969) 0.96

Biliary concentrations of piperacillin in patients undergoing cholecystectomy. Antimicrob Agents Chemother (1981) 0.96